Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma
- PMID: 2401730
- PMCID: PMC502641
- DOI: 10.1136/jcp.43.8.630
Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma
Abstract
A study of 260 patients with non-Hodgkin's lymphoma (NHL) who underwent bilateral bone marrow biopsy at initial diagnosis showed marrow disease in 99 (38%) cases. The highest incidence of disease (83%) was seen in small lymphocytic lymphoma (SLL) and the lowest (19%) in diffuse large cell lymphoma (DLCL). Among cases with positive marrows, disease was bilateral in all 15 cases of SLL but in only 10 of 20 (50%) of the DLCL cases. In 30 of 99 (30%) positive marrows disease was unilateral. Follicular lymphomas were strongly associated with a paratrabecular pattern, with 40 of 45 positive cases showing this. Discordant histology was seen in six of 20 positive cases of DLCL and two of 37 positive cases of follicular small cleaved cell lymphomas (FSCCL). A bone marrow aspirate was positive in only 56 of the 99 (57%) cases. Peripheral blood disease was present in 15% of the bone marrow positive cases and in 6% of the cases overall. The incidence of marrow disease varies with the histological subtype of lymphoma. The paratrabecular pattern is associated with follicular lymphoma, and bilateral biopsy specimens increase the positivity rate in most subtypes of NHL.
Comment in
-
Bone marrow biopsy in non-Hodgkin's lymphoma.J Clin Pathol. 1991 Apr;44(4):350-1. doi: 10.1136/jcp.44.4.350. J Clin Pathol. 1991. PMID: 2030162 Free PMC article. No abstract available.
Similar articles
-
Bone marrow involvement in non-Hodgkin's lymphoma.Taiwan Yi Xue Hui Za Zhi. 1989 Feb;88(2):114-21. Taiwan Yi Xue Hui Za Zhi. 1989. PMID: 2769211
-
Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.Am J Surg Pathol. 2005 Dec;29(12):1549-57. doi: 10.1097/01.pas.0000182405.65041.8b. Am J Surg Pathol. 2005. PMID: 16327427
-
Bone marrow involvement by non-Hodgkin's lymphom.J Korean Med Sci. 1994 Oct;9(5):402-8. doi: 10.3346/jkms.1994.9.5.402. J Korean Med Sci. 1994. PMID: 7702789 Free PMC article.
-
[Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].Ai Zheng. 2005 Nov;24(11):1416-20. Ai Zheng. 2005. PMID: 16552975 Review. Chinese.
-
Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.Genes Chromosomes Cancer. 1998 May;22(1):72-8. Genes Chromosomes Cancer. 1998. PMID: 9591637 Review.
Cited by
-
Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis.Virchows Arch. 2005 Dec;447(6):920-37. doi: 10.1007/s00428-005-0070-8. Epub 2005 Oct 18. Virchows Arch. 2005. PMID: 16231177 Review.
-
Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.Kaohsiung J Med Sci. 2015 Mar;31(3):130-7. doi: 10.1016/j.kjms.2014.11.012. Epub 2014 Dec 26. Kaohsiung J Med Sci. 2015. PMID: 25744235 Free PMC article.
-
Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping.J Hematol. 2021 Feb;10(1):14-17. doi: 10.14740/jh766. Epub 2021 Feb 6. J Hematol. 2021. PMID: 33643504 Free PMC article.
-
Bone marrow trephine biopsy.J Clin Pathol. 2001 Oct;54(10):737-42. doi: 10.1136/jcp.54.10.737. J Clin Pathol. 2001. PMID: 11577117 Free PMC article.
-
[Utility and prognostic value of PET/CT, bone marrow biopsy and aspirate for detection of bone marrow involvement in diffuse large B-cell lymphoma].Zhonghua Xue Ye Xue Za Zhi. 2022 Aug 14;43(8):663-667. doi: 10.3760/cma.j.issn.0253-2727.2022.08.008. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 36709151 Free PMC article. Chinese.
References
MeSH terms
LinkOut - more resources
Full Text Sources